Previous studies indicated that IL-1β plays a vital role in the pathophysiology of cardiovascular diseases [9, 24], indicating that decrease IL-1β expression in smooth muscle cells decreases the production of atherosclerotic inflammatory factors and might prevent the progression of atherosclerosis. This evidence concerns the gene IL1B and cardiovascular disorder.